Back

The relationship between echocardiographically assessed E/Em and invasively measured left atrial pressure

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - multi topics Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Katerina Kroupova

Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)

7 More presentations in this session

Presentation thumbnail
Left atrial strain predicts one-year composite clinical outcome in patients with heart failure with preserved ejection fraction
Doctor S. Murat (Eskisehir, TR)
Abstract Slides
Presentation thumbnail
Cardiac magnetic resonance native skeletal muscle T1 relaxation time is associated with outcome in patients with heart failure with preserved ejection fraction
Doctor C. Kronberger (Vienna, AT)
Abstract Slides
Presentation thumbnail
A contemporary comparative analysis between AL and ATTR cardiac amyloidosis and the survival impact of referral to the National Amyloidosis Centre: a UK tertiary centre experience
Doctor L. Khweir (Birmingham, GB)
Abstract Slides
Presentation thumbnail
Lifelong bachelor status is associated with increased mortality in men with heart failure:a secondary analysis of the atherosclerosis risk in communities study
Doctor K. Leyba (Aurora, US)
Abstract Slides
Presentation thumbnail
Sodium-glucose cotransporter 2 inhibitors are safe and potentially beneficial for the treatment of heart failure in adult congenital heart disease
Doctor R. Neijenhuis (Leiden, NL)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - multi topics

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources